Opinion: 2022 could be the year for pharmaceutical marijuana
Despite the success of adult-use marijuana, 2022 is looking like the year pharmaceutical cannabis becomes a major market driver.
Canopy Growth
Cannabis producer Canopy Growth dropped from S&P/TSX 60 Index
Smiths Falls, Ontario-based cannabis producer Canopy Growth Corp. is being deleted from the S&P/TSX 60 Index.
Court tosses Canopy cannabis patent infringement lawsuit against GW Pharma
A Texas court has dismissed a lawsuit brought by Canadian cannabis producer Canopy Growth against GW Pharmaceuticals, although Canopy has the right to appeal the ruling.
Canada’s cannabis legalization review running late, as industry hopes for reforms
More than three years after Canada legalized and regulated recreational cannabis, the country’s legalization law is overdue for a checkup.
A mandatory review of the 2018 legislation, which was supposed to have begun months ago, has not been formally launched, MJBizDaily has learned.
Health Canada seized more than 35M grams of marijuana, 7,800 plants after inspections
Health Canada seized more than 35 million grams (77,162 pounds) of cannabis products and thousands of plants from federal license holders for regulatory shortfalls in the 2019-20 fiscal year, the federal regulator disclosed to MJBizDaily.
Canopy Growth loses CA$115 million in quarter on lower cannabis sales
Canopy Growth reported a net loss of 115 million Canadian dollars ($90 million) in its quarter ended Dec. 31, 2021, on lower cannabis sales in its important Canada market.
Canopy vows to ‘forge forward,’ says no mold issues in marijuana greenhouses
An executive at Canadian licensed producer Canopy Growth acknowledged that images circulating on social media depicting cannabis plants laden with powdery mildew were taken at its facility in Smiths Falls, Ontario.
However, Mario Castillo, vice president of manufacturing, said the photos are not representative of Canopy’s cultivation operations.
Key hearing begins in $600 million lawsuit against marijuana MSO Acreage
A New York state judge started hearing a case Tuesday on whether a Syracuse investor group can proceed with a $600 million lawsuit against marijuana multistate operator Acreage Holdings and others over a medical cannabis license.
Organigram loss narrows on brisk cannabis sales
New Brunswick cannabis producer Organigram’s loss narrowed to 1.3 million Canadian dollars ($1 million) as adult-use sales soared over 70% compared to the comparable year-ago period, according to the company’s first-quarter financial results released Tuesday.
Analysts cut hundreds of millions from Tilray, Canopy, Aurora marijuana sales forecasts
Analysts have slashed hundreds of millions of dollars off their 2022 sales forecasts for three Canadian cannabis producers, reflecting an increasingly competitive landscape across the adult-use industry, falling overall prices and poor execution by some executive teams.
MJBizDaily’s most-read cannabis business stories of 2021
With an ongoing pandemic, a new president and Congress and five new state cannabis markets worth a collective $5 billion, 2021 has been a year like no other for the cannabis industry.
Here’s a look back at MJBizDaily’s 10 most-read cannabis business stories of 2021.
How Auxly Cannabis beat ‘bigger’ Canadian rivals in 2021: Q&A with CEO Hugo Alves
Auxly Cannabis gained more share of Canada’s recreational marijuana market than any of its competitors in 2021, and the Toronto-based licensed producer has its sights set on even more.
